nodes	percent_of_prediction	percent_of_DWPC	metapath
Exemestane—Estrone—prostate cancer	0.183	0.467	CrCtD
Exemestane—Conjugated Estrogens—prostate cancer	0.161	0.411	CrCtD
Exemestane—CYP19A1—prostate cancer	0.1	0.68	CbGaD
Exemestane—Prednisone—prostate cancer	0.0476	0.121	CrCtD
Exemestane—CYP3A4—prostate cancer	0.047	0.32	CbGaD
Exemestane—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0218	0.207	CbGbCtD
Exemestane—Estropipate—Estramustine—prostate cancer	0.0192	0.0742	CrCrCtD
Exemestane—Conjugated Estrogens—Estramustine—prostate cancer	0.0192	0.0742	CrCrCtD
Exemestane—Testosterone—Abiraterone—prostate cancer	0.0176	0.0677	CrCrCtD
Exemestane—Estrone—Estradiol valerate/Dienogest—prostate cancer	0.0168	0.0647	CrCrCtD
Exemestane—Conjugated Estrogens—Estrone—prostate cancer	0.0153	0.0589	CrCrCtD
Exemestane—Estropipate—Estrone—prostate cancer	0.0153	0.0589	CrCrCtD
Exemestane—Estrone—Estramustine—prostate cancer	0.0143	0.055	CrCrCtD
Exemestane—Estropipate—Conjugated Estrogens—prostate cancer	0.0135	0.0519	CrCrCtD
Exemestane—Formestane—Estrone—prostate cancer	0.0119	0.046	CrCrCtD
Exemestane—Estropipate—Estradiol—prostate cancer	0.0116	0.0447	CrCrCtD
Exemestane—Conjugated Estrogens—Estradiol—prostate cancer	0.0116	0.0447	CrCrCtD
Exemestane—CYP3A4—Bicalutamide—prostate cancer	0.0114	0.109	CbGbCtD
Exemestane—Conjugated Estrogens—Ethinyl Estradiol—prostate cancer	0.0113	0.0436	CrCrCtD
Exemestane—Estropipate—Ethinyl Estradiol—prostate cancer	0.0113	0.0436	CrCrCtD
Exemestane—CYP3A4—Estramustine—prostate cancer	0.0106	0.101	CbGbCtD
Exemestane—Formestane—Conjugated Estrogens—prostate cancer	0.0105	0.0405	CrCrCtD
Exemestane—Estrone—Conjugated Estrogens—prostate cancer	0.00997	0.0385	CrCrCtD
Exemestane—CYP3A4—Flutamide—prostate cancer	0.00947	0.09	CbGbCtD
Exemestane—CYP3A4—Abiraterone—prostate cancer	0.00947	0.09	CbGbCtD
Exemestane—Estrone—Estradiol—prostate cancer	0.00858	0.0331	CrCrCtD
Exemestane—Estrone—Ethinyl Estradiol—prostate cancer	0.00838	0.0323	CrCrCtD
Exemestane—Testolactone—Estrone—prostate cancer	0.00745	0.0287	CrCrCtD
Exemestane—Testosterone—Estramustine—prostate cancer	0.00729	0.0281	CrCrCtD
Exemestane—CYP3A4—Cabazitaxel—prostate cancer	0.00701	0.0666	CbGbCtD
Exemestane—CYP3A4—Estrone—prostate cancer	0.00685	0.0651	CbGbCtD
Exemestane—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0061	0.058	CbGbCtD
Exemestane—Testosterone—Estrone—prostate cancer	0.00579	0.0223	CrCrCtD
Exemestane—CYP3A4—Conjugated Estrogens—prostate cancer	0.00448	0.0426	CbGbCtD
Exemestane—Testosterone—Estradiol—prostate cancer	0.00439	0.0169	CrCrCtD
Exemestane—CYP3A4—Mitoxantrone—prostate cancer	0.00407	0.0387	CbGbCtD
Exemestane—CYP3A4—Estradiol—prostate cancer	0.00393	0.0374	CbGbCtD
Exemestane—CYP3A4—Prednisone—prostate cancer	0.00338	0.0321	CbGbCtD
Exemestane—CYP3A4—Etoposide—prostate cancer	0.00257	0.0244	CbGbCtD
Exemestane—CYP3A4—Docetaxel—prostate cancer	0.00235	0.0223	CbGbCtD
Exemestane—Testolactone—Prednisone—prostate cancer	0.00194	0.00747	CrCrCtD
Exemestane—CYP3A4—Doxorubicin—prostate cancer	0.00175	0.0166	CbGbCtD
Exemestane—Fluprednidene Acetate—Prednisone—prostate cancer	0.00161	0.00621	CrCrCtD
Exemestane—Loteprednol—Prednisone—prostate cancer	0.00161	0.00621	CrCrCtD
Exemestane—Methylprednisolone—Prednisone—prostate cancer	0.0015	0.0058	CrCrCtD
Exemestane—Prednisolone—Prednisone—prostate cancer	0.00147	0.00568	CrCrCtD
Exemestane—CYP19A1—semen—prostate cancer	0.00145	0.537	CbGeAlD
Exemestane—CYP3A4—urine—prostate cancer	0.000492	0.182	CbGeAlD
Exemestane—CYP19A1—prostate gland—prostate cancer	0.000364	0.135	CbGeAlD
Exemestane—CYP19A1—testis—prostate cancer	0.00016	0.0593	CbGeAlD
Exemestane—CYP3A4—renal system—prostate cancer	0.00012	0.0445	CbGeAlD
Exemestane—CYP19A1—lymph node—prostate cancer	0.000116	0.043	CbGeAlD
Exemestane—Testosterone—CYP3A43—prostate cancer	9.74e-05	0.0625	CrCbGaD
Exemestane—Testolactone—CYP19A1—prostate cancer	9.54e-05	0.0612	CrCbGaD
Exemestane—Estropipate—ESR2—prostate cancer	8.89e-05	0.057	CrCbGaD
Exemestane—Estropipate—SHBG—prostate cancer	8.1e-05	0.052	CrCbGaD
Exemestane—Estropipate—SLC22A1—prostate cancer	8e-05	0.0513	CrCbGaD
Exemestane—Loteprednol—NR3C1—prostate cancer	7.05e-05	0.0452	CrCbGaD
Exemestane—Conjugated Estrogens—COMT—prostate cancer	5.95e-05	0.0382	CrCbGaD
Exemestane—Conjugated Estrogens—ESR2—prostate cancer	5.55e-05	0.0356	CrCbGaD
Exemestane—Estrone—ESR2—prostate cancer	5.53e-05	0.0355	CrCbGaD
Exemestane—Estropipate—ESR1—prostate cancer	5.47e-05	0.0351	CrCbGaD
Exemestane—Estrone—SHBG—prostate cancer	5.04e-05	0.0324	CrCbGaD
Exemestane—Estrone—CYP1B1—prostate cancer	5.04e-05	0.0324	CrCbGaD
Exemestane—Methylprednisolone—NR3C1—prostate cancer	4.39e-05	0.0282	CrCbGaD
Exemestane—Testosterone—SLC22A3—prostate cancer	4.22e-05	0.0271	CrCbGaD
Exemestane—Estrone—CYP3A5—prostate cancer	4.02e-05	0.0258	CrCbGaD
Exemestane—Prednisolone—CYP2A6—prostate cancer	4.01e-05	0.0258	CrCbGaD
Exemestane—Conjugated Estrogens—ESR1—prostate cancer	3.42e-05	0.0219	CrCbGaD
Exemestane—Estrone—ESR1—prostate cancer	3.41e-05	0.0219	CrCbGaD
Exemestane—Prednisone—NR3C1—prostate cancer	3.36e-05	0.0216	CrCbGaD
Exemestane—Prednisolone—NR3C1—prostate cancer	3.1e-05	0.0199	CrCbGaD
Exemestane—Testosterone—SHBG—prostate cancer	3.07e-05	0.0197	CrCbGaD
Exemestane—Testosterone—CYP1B1—prostate cancer	3.07e-05	0.0197	CrCbGaD
Exemestane—Prednisone—CYP2C19—prostate cancer	3.06e-05	0.0197	CrCbGaD
Exemestane—Testosterone—SLC22A1—prostate cancer	3.03e-05	0.0194	CrCbGaD
Exemestane—Estropipate—CYP3A4—prostate cancer	2.79e-05	0.0179	CrCbGaD
Exemestane—Estrone—CYP2E1—prostate cancer	2.76e-05	0.0177	CrCbGaD
Exemestane—Estrone—CYP1A1—prostate cancer	2.72e-05	0.0175	CrCbGaD
Exemestane—Testosterone—AR—prostate cancer	2.69e-05	0.0173	CrCbGaD
Exemestane—Methylprednisolone—CYP3A4—prostate cancer	2.55e-05	0.0163	CrCbGaD
Exemestane—Testosterone—CYP3A5—prostate cancer	2.44e-05	0.0157	CrCbGaD
Exemestane—Testosterone—CYP19A1—prostate cancer	2.25e-05	0.0144	CrCbGaD
Exemestane—Prednisone—CYP3A4—prostate cancer	1.95e-05	0.0125	CrCbGaD
Exemestane—Prednisolone—CYP3A4—prostate cancer	1.79e-05	0.0115	CrCbGaD
Exemestane—Conjugated Estrogens—CYP3A4—prostate cancer	1.74e-05	0.0112	CrCbGaD
Exemestane—Estrone—CYP3A4—prostate cancer	1.74e-05	0.0112	CrCbGaD
Exemestane—Chest pain—Capecitabine—prostate cancer	1.67e-05	0.000252	CcSEcCtD
Exemestane—Myalgia—Capecitabine—prostate cancer	1.67e-05	0.000252	CcSEcCtD
Exemestane—Confusional state—Docetaxel—prostate cancer	1.67e-05	0.000252	CcSEcCtD
Exemestane—Anxiety—Capecitabine—prostate cancer	1.67e-05	0.000251	CcSEcCtD
Exemestane—Testosterone—CYP2C19—prostate cancer	1.66e-05	0.0107	CrCbGaD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	1.66e-05	0.00025	CcSEcCtD
Exemestane—Testosterone—CYP1A1—prostate cancer	1.66e-05	0.0106	CrCbGaD
Exemestane—Hepatobiliary disease—Epirubicin—prostate cancer	1.66e-05	0.00025	CcSEcCtD
Exemestane—Oedema—Docetaxel—prostate cancer	1.66e-05	0.00025	CcSEcCtD
Exemestane—Weight increased—Doxorubicin—prostate cancer	1.65e-05	0.000249	CcSEcCtD
Exemestane—Infection—Docetaxel—prostate cancer	1.64e-05	0.000248	CcSEcCtD
Exemestane—Sinusitis—Epirubicin—prostate cancer	1.64e-05	0.000248	CcSEcCtD
Exemestane—Feeling abnormal—Etoposide—prostate cancer	1.64e-05	0.000247	CcSEcCtD
Exemestane—Diarrhoea—Mitoxantrone—prostate cancer	1.64e-05	0.000247	CcSEcCtD
Exemestane—Vomiting—Estradiol—prostate cancer	1.63e-05	0.000246	CcSEcCtD
Exemestane—Gastrointestinal pain—Etoposide—prostate cancer	1.63e-05	0.000246	CcSEcCtD
Exemestane—Nervous system disorder—Docetaxel—prostate cancer	1.62e-05	0.000245	CcSEcCtD
Exemestane—Thrombocytopenia—Docetaxel—prostate cancer	1.62e-05	0.000244	CcSEcCtD
Exemestane—Rash—Estradiol—prostate cancer	1.62e-05	0.000244	CcSEcCtD
Exemestane—Dermatitis—Estradiol—prostate cancer	1.62e-05	0.000244	CcSEcCtD
Exemestane—Confusional state—Capecitabine—prostate cancer	1.62e-05	0.000244	CcSEcCtD
Exemestane—Headache—Estradiol—prostate cancer	1.61e-05	0.000243	CcSEcCtD
Exemestane—Skin disorder—Docetaxel—prostate cancer	1.61e-05	0.000242	CcSEcCtD
Exemestane—Oedema—Capecitabine—prostate cancer	1.6e-05	0.000242	CcSEcCtD
Exemestane—Infection—Capecitabine—prostate cancer	1.59e-05	0.00024	CcSEcCtD
Exemestane—Neuropathy peripheral—Doxorubicin—prostate cancer	1.59e-05	0.000239	CcSEcCtD
Exemestane—Urticaria—Etoposide—prostate cancer	1.58e-05	0.000239	CcSEcCtD
Exemestane—Haemoglobin—Epirubicin—prostate cancer	1.58e-05	0.000238	CcSEcCtD
Exemestane—Anorexia—Docetaxel—prostate cancer	1.58e-05	0.000238	CcSEcCtD
Exemestane—Malaise—Prednisone—prostate cancer	1.58e-05	0.000238	CcSEcCtD
Exemestane—Rhinitis—Epirubicin—prostate cancer	1.58e-05	0.000238	CcSEcCtD
Exemestane—Abdominal pain—Etoposide—prostate cancer	1.57e-05	0.000237	CcSEcCtD
Exemestane—Body temperature increased—Etoposide—prostate cancer	1.57e-05	0.000237	CcSEcCtD
Exemestane—Urinary tract infection—Doxorubicin—prostate cancer	1.57e-05	0.000237	CcSEcCtD
Exemestane—Nervous system disorder—Capecitabine—prostate cancer	1.57e-05	0.000237	CcSEcCtD
Exemestane—Hepatitis—Epirubicin—prostate cancer	1.57e-05	0.000237	CcSEcCtD
Exemestane—Haemorrhage—Epirubicin—prostate cancer	1.57e-05	0.000237	CcSEcCtD
Exemestane—Thrombocytopenia—Capecitabine—prostate cancer	1.57e-05	0.000237	CcSEcCtD
Exemestane—Hypoaesthesia—Epirubicin—prostate cancer	1.56e-05	0.000236	CcSEcCtD
Exemestane—Pharyngitis—Epirubicin—prostate cancer	1.56e-05	0.000235	CcSEcCtD
Exemestane—Skin disorder—Capecitabine—prostate cancer	1.56e-05	0.000235	CcSEcCtD
Exemestane—Sweating—Doxorubicin—prostate cancer	1.55e-05	0.000234	CcSEcCtD
Exemestane—Hyperhidrosis—Capecitabine—prostate cancer	1.55e-05	0.000234	CcSEcCtD
Exemestane—Oedema peripheral—Epirubicin—prostate cancer	1.55e-05	0.000233	CcSEcCtD
Exemestane—Hepatobiliary disease—Doxorubicin—prostate cancer	1.53e-05	0.000231	CcSEcCtD
Exemestane—Anorexia—Capecitabine—prostate cancer	1.53e-05	0.00023	CcSEcCtD
Exemestane—Nausea—Estradiol—prostate cancer	1.53e-05	0.00023	CcSEcCtD
Exemestane—Vomiting—Mitoxantrone—prostate cancer	1.52e-05	0.00023	CcSEcCtD
Exemestane—Sinusitis—Doxorubicin—prostate cancer	1.52e-05	0.000229	CcSEcCtD
Exemestane—Visual impairment—Epirubicin—prostate cancer	1.51e-05	0.000228	CcSEcCtD
Exemestane—Hypertension—Prednisone—prostate cancer	1.51e-05	0.000228	CcSEcCtD
Exemestane—Rash—Mitoxantrone—prostate cancer	1.51e-05	0.000228	CcSEcCtD
Exemestane—Dermatitis—Mitoxantrone—prostate cancer	1.51e-05	0.000227	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Docetaxel—prostate cancer	1.51e-05	0.000227	CcSEcCtD
Exemestane—Headache—Mitoxantrone—prostate cancer	1.5e-05	0.000226	CcSEcCtD
Exemestane—Insomnia—Docetaxel—prostate cancer	1.5e-05	0.000226	CcSEcCtD
Exemestane—Myalgia—Prednisone—prostate cancer	1.49e-05	0.000225	CcSEcCtD
Exemestane—Arthralgia—Prednisone—prostate cancer	1.49e-05	0.000225	CcSEcCtD
Exemestane—Paraesthesia—Docetaxel—prostate cancer	1.49e-05	0.000224	CcSEcCtD
Exemestane—Erythema multiforme—Epirubicin—prostate cancer	1.49e-05	0.000224	CcSEcCtD
Exemestane—Anxiety—Prednisone—prostate cancer	1.48e-05	0.000224	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	1.48e-05	0.000223	CcSEcCtD
Exemestane—Dyspnoea—Docetaxel—prostate cancer	1.48e-05	0.000222	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	1.47e-05	0.000565	CbGpPWpGaD
Exemestane—Hypersensitivity—Etoposide—prostate cancer	1.47e-05	0.000221	CcSEcCtD
Exemestane—Haemoglobin—Doxorubicin—prostate cancer	1.46e-05	0.00022	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Capecitabine—prostate cancer	1.46e-05	0.00022	CcSEcCtD
Exemestane—Cardiac disorder—Epirubicin—prostate cancer	1.46e-05	0.00022	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—GSTA1—prostate cancer	1.46e-05	0.00056	CbGpPWpGaD
Exemestane—Rhinitis—Doxorubicin—prostate cancer	1.46e-05	0.00022	CcSEcCtD
Exemestane—Dyspepsia—Docetaxel—prostate cancer	1.46e-05	0.00022	CcSEcCtD
Exemestane—Haemorrhage—Doxorubicin—prostate cancer	1.45e-05	0.000219	CcSEcCtD
Exemestane—Hepatitis—Doxorubicin—prostate cancer	1.45e-05	0.000219	CcSEcCtD
Exemestane—Insomnia—Capecitabine—prostate cancer	1.45e-05	0.000219	CcSEcCtD
Exemestane—Hypoaesthesia—Doxorubicin—prostate cancer	1.45e-05	0.000218	CcSEcCtD
Exemestane—Pharyngitis—Doxorubicin—prostate cancer	1.44e-05	0.000218	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—GSTO1—prostate cancer	1.44e-05	0.000554	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—NAT2—prostate cancer	1.44e-05	0.000554	CbGpPWpGaD
Exemestane—Paraesthesia—Capecitabine—prostate cancer	1.44e-05	0.000217	CcSEcCtD
Exemestane—Decreased appetite—Docetaxel—prostate cancer	1.44e-05	0.000217	CcSEcCtD
Exemestane—Oedema peripheral—Doxorubicin—prostate cancer	1.43e-05	0.000216	CcSEcCtD
Exemestane—Gastrointestinal disorder—Docetaxel—prostate cancer	1.43e-05	0.000215	CcSEcCtD
Exemestane—Asthenia—Etoposide—prostate cancer	1.43e-05	0.000215	CcSEcCtD
Exemestane—Dyspnoea—Capecitabine—prostate cancer	1.43e-05	0.000215	CcSEcCtD
Exemestane—Oedema—Prednisone—prostate cancer	1.43e-05	0.000215	CcSEcCtD
Exemestane—Fatigue—Docetaxel—prostate cancer	1.43e-05	0.000215	CcSEcCtD
Exemestane—Nausea—Mitoxantrone—prostate cancer	1.42e-05	0.000214	CcSEcCtD
Exemestane—CYP3A4—Metapathway biotransformation—NAT2—prostate cancer	1.42e-05	0.000546	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—GSTO1—prostate cancer	1.42e-05	0.000546	CbGpPWpGaD
Exemestane—Immune system disorder—Epirubicin—prostate cancer	1.42e-05	0.000214	CcSEcCtD
Exemestane—Infection—Prednisone—prostate cancer	1.42e-05	0.000214	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CASP3—prostate cancer	1.42e-05	0.000544	CbGpPWpGaD
Exemestane—Pain—Docetaxel—prostate cancer	1.42e-05	0.000213	CcSEcCtD
Exemestane—Constipation—Docetaxel—prostate cancer	1.42e-05	0.000213	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	1.41e-05	0.000543	CbGpPWpGaD
Exemestane—Dyspepsia—Capecitabine—prostate cancer	1.41e-05	0.000213	CcSEcCtD
Exemestane—Pruritus—Etoposide—prostate cancer	1.41e-05	0.000212	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	1.41e-05	0.00054	CbGpPWpGaD
Exemestane—Visual impairment—Doxorubicin—prostate cancer	1.4e-05	0.000211	CcSEcCtD
Exemestane—Nervous system disorder—Prednisone—prostate cancer	1.4e-05	0.000211	CcSEcCtD
Exemestane—Decreased appetite—Capecitabine—prostate cancer	1.39e-05	0.00021	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	1.39e-05	0.000535	CbGpPWpGaD
Exemestane—Alopecia—Epirubicin—prostate cancer	1.39e-05	0.000209	CcSEcCtD
Exemestane—Skin disorder—Prednisone—prostate cancer	1.39e-05	0.000209	CcSEcCtD
Exemestane—Gastrointestinal disorder—Capecitabine—prostate cancer	1.38e-05	0.000209	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—CYP2C18—prostate cancer	1.38e-05	0.000531	CbGpPWpGaD
Exemestane—Fatigue—Capecitabine—prostate cancer	1.38e-05	0.000208	CcSEcCtD
Exemestane—Hyperhidrosis—Prednisone—prostate cancer	1.38e-05	0.000208	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CCND1—prostate cancer	1.38e-05	0.00053	CbGpPWpGaD
Exemestane—Mental disorder—Epirubicin—prostate cancer	1.38e-05	0.000208	CcSEcCtD
Exemestane—Erythema multiforme—Doxorubicin—prostate cancer	1.37e-05	0.000207	CcSEcCtD
Exemestane—Constipation—Capecitabine—prostate cancer	1.37e-05	0.000207	CcSEcCtD
Exemestane—Pain—Capecitabine—prostate cancer	1.37e-05	0.000207	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—prostate cancer	1.37e-05	0.000525	CbGpPWpGaD
Exemestane—Feeling abnormal—Docetaxel—prostate cancer	1.36e-05	0.000206	CcSEcCtD
Exemestane—CYP3A4—Metapathway biotransformation—CYP2C18—prostate cancer	1.36e-05	0.000524	CbGpPWpGaD
Exemestane—Diarrhoea—Etoposide—prostate cancer	1.36e-05	0.000205	CcSEcCtD
Exemestane—Anorexia—Prednisone—prostate cancer	1.36e-05	0.000205	CcSEcCtD
Exemestane—Gastrointestinal pain—Docetaxel—prostate cancer	1.35e-05	0.000204	CcSEcCtD
Exemestane—Cardiac disorder—Doxorubicin—prostate cancer	1.35e-05	0.000203	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—PTEN—prostate cancer	1.33e-05	0.000511	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	1.33e-05	0.00051	CbGpPWpGaD
Exemestane—Back pain—Epirubicin—prostate cancer	1.32e-05	0.000199	CcSEcCtD
Exemestane—Feeling abnormal—Capecitabine—prostate cancer	1.32e-05	0.000199	CcSEcCtD
Exemestane—Dizziness—Etoposide—prostate cancer	1.32e-05	0.000199	CcSEcCtD
Exemestane—Muscle spasms—Epirubicin—prostate cancer	1.32e-05	0.000198	CcSEcCtD
Exemestane—Immune system disorder—Doxorubicin—prostate cancer	1.31e-05	0.000198	CcSEcCtD
Exemestane—CYP19A1—Metabolism—HPGD—prostate cancer	1.31e-05	0.000503	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—B4GALT4—prostate cancer	1.31e-05	0.000503	CbGpPWpGaD
Exemestane—Gastrointestinal pain—Capecitabine—prostate cancer	1.31e-05	0.000198	CcSEcCtD
Exemestane—Abdominal pain—Docetaxel—prostate cancer	1.31e-05	0.000197	CcSEcCtD
Exemestane—Body temperature increased—Docetaxel—prostate cancer	1.31e-05	0.000197	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Prednisone—prostate cancer	1.3e-05	0.000196	CcSEcCtD
Exemestane—Insomnia—Prednisone—prostate cancer	1.29e-05	0.000195	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—SULT2A1—prostate cancer	1.29e-05	0.000493	CbGpPWpGaD
Exemestane—Alopecia—Doxorubicin—prostate cancer	1.29e-05	0.000194	CcSEcCtD
Exemestane—Paraesthesia—Prednisone—prostate cancer	1.28e-05	0.000193	CcSEcCtD
Exemestane—Mental disorder—Doxorubicin—prostate cancer	1.27e-05	0.000192	CcSEcCtD
Exemestane—Urticaria—Capecitabine—prostate cancer	1.27e-05	0.000192	CcSEcCtD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	1.27e-05	0.000488	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—EP300—prostate cancer	1.27e-05	0.000488	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—SULT2A1—prostate cancer	1.27e-05	0.000487	CbGpPWpGaD
Exemestane—Body temperature increased—Capecitabine—prostate cancer	1.27e-05	0.000191	CcSEcCtD
Exemestane—Abdominal pain—Capecitabine—prostate cancer	1.27e-05	0.000191	CcSEcCtD
Exemestane—Vomiting—Etoposide—prostate cancer	1.27e-05	0.000191	CcSEcCtD
Exemestane—Dyspepsia—Prednisone—prostate cancer	1.26e-05	0.000189	CcSEcCtD
Exemestane—Rash—Etoposide—prostate cancer	1.26e-05	0.000189	CcSEcCtD
Exemestane—Dermatitis—Etoposide—prostate cancer	1.25e-05	0.000189	CcSEcCtD
Exemestane—Headache—Etoposide—prostate cancer	1.25e-05	0.000188	CcSEcCtD
Exemestane—Decreased appetite—Prednisone—prostate cancer	1.24e-05	0.000187	CcSEcCtD
Exemestane—Malaise—Epirubicin—prostate cancer	1.23e-05	0.000186	CcSEcCtD
Exemestane—CYP19A1—Metabolism—TNFRSF21—prostate cancer	1.23e-05	0.000473	CbGpPWpGaD
Exemestane—Fatigue—Prednisone—prostate cancer	1.23e-05	0.000186	CcSEcCtD
Exemestane—Leukopenia—Epirubicin—prostate cancer	1.22e-05	0.000185	CcSEcCtD
Exemestane—Back pain—Doxorubicin—prostate cancer	1.22e-05	0.000185	CcSEcCtD
Exemestane—Constipation—Prednisone—prostate cancer	1.22e-05	0.000184	CcSEcCtD
Exemestane—Hypersensitivity—Docetaxel—prostate cancer	1.22e-05	0.000184	CcSEcCtD
Exemestane—Muscle spasms—Doxorubicin—prostate cancer	1.22e-05	0.000183	CcSEcCtD
Exemestane—CYP3A4—Metapathway biotransformation—GPX3—prostate cancer	1.21e-05	0.000464	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—prostate cancer	1.2e-05	0.000462	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—MTAP—prostate cancer	1.2e-05	0.00046	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP7B1—prostate cancer	1.2e-05	0.00046	CbGpPWpGaD
Exemestane—CYP3A4—Tryptophan metabolism—MDM2—prostate cancer	1.2e-05	0.000459	CbGpPWpGaD
Exemestane—Cough—Epirubicin—prostate cancer	1.19e-05	0.00018	CcSEcCtD
Exemestane—Asthenia—Docetaxel—prostate cancer	1.19e-05	0.000179	CcSEcCtD
Exemestane—Nausea—Etoposide—prostate cancer	1.18e-05	0.000178	CcSEcCtD
Exemestane—Hypertension—Epirubicin—prostate cancer	1.18e-05	0.000178	CcSEcCtD
Exemestane—Hypersensitivity—Capecitabine—prostate cancer	1.18e-05	0.000178	CcSEcCtD
Exemestane—Feeling abnormal—Prednisone—prostate cancer	1.18e-05	0.000177	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.17e-05	0.00045	CbGpPWpGaD
Exemestane—Pruritus—Docetaxel—prostate cancer	1.17e-05	0.000177	CcSEcCtD
Exemestane—CYP19A1—Metabolism—SULT1E1—prostate cancer	1.17e-05	0.000449	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SRD5A1—prostate cancer	1.17e-05	0.000449	CbGpPWpGaD
Exemestane—Gastrointestinal pain—Prednisone—prostate cancer	1.17e-05	0.000176	CcSEcCtD
Exemestane—Myalgia—Epirubicin—prostate cancer	1.16e-05	0.000176	CcSEcCtD
Exemestane—Chest pain—Epirubicin—prostate cancer	1.16e-05	0.000176	CcSEcCtD
Exemestane—Arthralgia—Epirubicin—prostate cancer	1.16e-05	0.000176	CcSEcCtD
Exemestane—Anxiety—Epirubicin—prostate cancer	1.16e-05	0.000175	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.16e-05	0.000174	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—HPGDS—prostate cancer	1.15e-05	0.000443	CbGpPWpGaD
Exemestane—Asthenia—Capecitabine—prostate cancer	1.15e-05	0.000173	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—CYP2C19—prostate cancer	1.15e-05	0.00044	CbGpPWpGaD
Exemestane—Malaise—Doxorubicin—prostate cancer	1.14e-05	0.000172	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1.14e-05	0.000436	CbGpPWpGaD
Exemestane—Urticaria—Prednisone—prostate cancer	1.13e-05	0.000171	CcSEcCtD
Exemestane—Pruritus—Capecitabine—prostate cancer	1.13e-05	0.000171	CcSEcCtD
Exemestane—Leukopenia—Doxorubicin—prostate cancer	1.13e-05	0.000171	CcSEcCtD
Exemestane—Diarrhoea—Docetaxel—prostate cancer	1.13e-05	0.000171	CcSEcCtD
Exemestane—CYP3A4—Metapathway biotransformation—CYP2C19—prostate cancer	1.13e-05	0.000434	CbGpPWpGaD
Exemestane—Body temperature increased—Prednisone—prostate cancer	1.13e-05	0.00017	CcSEcCtD
Exemestane—Abdominal pain—Prednisone—prostate cancer	1.13e-05	0.00017	CcSEcCtD
Exemestane—Confusional state—Epirubicin—prostate cancer	1.13e-05	0.00017	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.12e-05	0.000429	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTT1—prostate cancer	1.12e-05	0.000429	CbGpPWpGaD
Exemestane—Oedema—Epirubicin—prostate cancer	1.12e-05	0.000168	CcSEcCtD
Exemestane—CYP19A1—Metabolism—HSD17B3—prostate cancer	1.12e-05	0.000428	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ACSL4—prostate cancer	1.12e-05	0.000428	CbGpPWpGaD
Exemestane—Infection—Epirubicin—prostate cancer	1.11e-05	0.000167	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—MYC—prostate cancer	1.11e-05	0.000425	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP2A6—prostate cancer	1.11e-05	0.000424	CbGpPWpGaD
Exemestane—Cough—Doxorubicin—prostate cancer	1.1e-05	0.000167	CcSEcCtD
Exemestane—Diarrhoea—Capecitabine—prostate cancer	1.1e-05	0.000165	CcSEcCtD
Exemestane—Nervous system disorder—Epirubicin—prostate cancer	1.1e-05	0.000165	CcSEcCtD
Exemestane—Dizziness—Docetaxel—prostate cancer	1.09e-05	0.000165	CcSEcCtD
Exemestane—Thrombocytopenia—Epirubicin—prostate cancer	1.09e-05	0.000165	CcSEcCtD
Exemestane—Hypertension—Doxorubicin—prostate cancer	1.09e-05	0.000165	CcSEcCtD
Exemestane—Skin disorder—Epirubicin—prostate cancer	1.08e-05	0.000163	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—EGFR—prostate cancer	1.08e-05	0.000416	CbGpPWpGaD
Exemestane—Hyperhidrosis—Epirubicin—prostate cancer	1.08e-05	0.000163	CcSEcCtD
Exemestane—Myalgia—Doxorubicin—prostate cancer	1.08e-05	0.000162	CcSEcCtD
Exemestane—Chest pain—Doxorubicin—prostate cancer	1.08e-05	0.000162	CcSEcCtD
Exemestane—Arthralgia—Doxorubicin—prostate cancer	1.08e-05	0.000162	CcSEcCtD
Exemestane—Anxiety—Doxorubicin—prostate cancer	1.07e-05	0.000162	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.07e-05	0.000161	CcSEcCtD
Exemestane—CYP19A1—Metabolism—ARG2—prostate cancer	1.07e-05	0.00041	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PHGDH—prostate cancer	1.07e-05	0.00041	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—UMPS—prostate cancer	1.07e-05	0.00041	CbGpPWpGaD
Exemestane—Anorexia—Epirubicin—prostate cancer	1.06e-05	0.00016	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.06e-05	0.000408	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—AKR1C3—prostate cancer	1.06e-05	0.000407	CbGpPWpGaD
Exemestane—Dizziness—Capecitabine—prostate cancer	1.06e-05	0.00016	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—CYP17A1—prostate cancer	1.06e-05	0.000406	CbGpPWpGaD
Exemestane—Testosterone—CYP3A4—prostate cancer	1.06e-05	0.00678	CrCbGaD
Exemestane—Vomiting—Docetaxel—prostate cancer	1.05e-05	0.000159	CcSEcCtD
Exemestane—Hypersensitivity—Prednisone—prostate cancer	1.05e-05	0.000159	CcSEcCtD
Exemestane—CYP19A1—Metabolism—LDHB—prostate cancer	1.05e-05	0.000403	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP17A1—prostate cancer	1.04e-05	0.000401	CbGpPWpGaD
Exemestane—Rash—Docetaxel—prostate cancer	1.04e-05	0.000157	CcSEcCtD
Exemestane—Dermatitis—Docetaxel—prostate cancer	1.04e-05	0.000157	CcSEcCtD
Exemestane—Confusional state—Doxorubicin—prostate cancer	1.04e-05	0.000157	CcSEcCtD
Exemestane—Headache—Docetaxel—prostate cancer	1.04e-05	0.000156	CcSEcCtD
Exemestane—Oedema—Doxorubicin—prostate cancer	1.03e-05	0.000156	CcSEcCtD
Exemestane—CYP19A1—Metabolism—CYP3A5—prostate cancer	1.03e-05	0.000395	CbGpPWpGaD
Exemestane—Infection—Doxorubicin—prostate cancer	1.03e-05	0.000155	CcSEcCtD
Exemestane—Asthenia—Prednisone—prostate cancer	1.02e-05	0.000154	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—KRAS—prostate cancer	1.02e-05	0.000393	CbGpPWpGaD
Exemestane—Vomiting—Capecitabine—prostate cancer	1.02e-05	0.000154	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.02e-05	0.000153	CcSEcCtD
Exemestane—Nervous system disorder—Doxorubicin—prostate cancer	1.01e-05	0.000153	CcSEcCtD
Exemestane—Thrombocytopenia—Doxorubicin—prostate cancer	1.01e-05	0.000152	CcSEcCtD
Exemestane—Rash—Capecitabine—prostate cancer	1.01e-05	0.000152	CcSEcCtD
Exemestane—Pruritus—Prednisone—prostate cancer	1.01e-05	0.000152	CcSEcCtD
Exemestane—Insomnia—Epirubicin—prostate cancer	1.01e-05	0.000152	CcSEcCtD
Exemestane—Dermatitis—Capecitabine—prostate cancer	1.01e-05	0.000152	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—NCOA2—prostate cancer	1.01e-05	0.000387	CbGpPWpGaD
Exemestane—Headache—Capecitabine—prostate cancer	1e-05	0.000151	CcSEcCtD
Exemestane—Skin disorder—Doxorubicin—prostate cancer	1e-05	0.000151	CcSEcCtD
Exemestane—Paraesthesia—Epirubicin—prostate cancer	1e-05	0.000151	CcSEcCtD
Exemestane—Hyperhidrosis—Doxorubicin—prostate cancer	9.99e-06	0.000151	CcSEcCtD
Exemestane—Dyspnoea—Epirubicin—prostate cancer	9.95e-06	0.00015	CcSEcCtD
Exemestane—CYP19A1—Metabolism—PDHA1—prostate cancer	9.94e-06	0.000382	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTA3—prostate cancer	9.94e-06	0.000382	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—TCN2—prostate cancer	9.94e-06	0.000382	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—UCP3—prostate cancer	9.94e-06	0.000382	CbGpPWpGaD
Exemestane—Anorexia—Doxorubicin—prostate cancer	9.85e-06	0.000148	CcSEcCtD
Exemestane—Nausea—Docetaxel—prostate cancer	9.83e-06	0.000148	CcSEcCtD
Exemestane—Dyspepsia—Epirubicin—prostate cancer	9.83e-06	0.000148	CcSEcCtD
Exemestane—Diarrhoea—Prednisone—prostate cancer	9.77e-06	0.000147	CcSEcCtD
Exemestane—Decreased appetite—Epirubicin—prostate cancer	9.71e-06	0.000146	CcSEcCtD
Exemestane—Gastrointestinal disorder—Epirubicin—prostate cancer	9.64e-06	0.000145	CcSEcCtD
Exemestane—Fatigue—Epirubicin—prostate cancer	9.63e-06	0.000145	CcSEcCtD
Exemestane—Constipation—Epirubicin—prostate cancer	9.55e-06	0.000144	CcSEcCtD
Exemestane—Pain—Epirubicin—prostate cancer	9.55e-06	0.000144	CcSEcCtD
Exemestane—Nausea—Capecitabine—prostate cancer	9.52e-06	0.000144	CcSEcCtD
Exemestane—CYP19A1—Metabolism—SLC22A3—prostate cancer	9.48e-06	0.000364	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HSD3B1—prostate cancer	9.48e-06	0.000364	CbGpPWpGaD
Exemestane—Dizziness—Prednisone—prostate cancer	9.44e-06	0.000142	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Doxorubicin—prostate cancer	9.41e-06	0.000142	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—CYP2E1—prostate cancer	9.4e-06	0.000361	CbGpPWpGaD
Exemestane—Insomnia—Doxorubicin—prostate cancer	9.34e-06	0.000141	CcSEcCtD
Exemestane—Paraesthesia—Doxorubicin—prostate cancer	9.28e-06	0.00014	CcSEcCtD
Exemestane—CYP3A4—Metapathway biotransformation—CYP2E1—prostate cancer	9.27e-06	0.000356	CbGpPWpGaD
Exemestane—Dyspnoea—Doxorubicin—prostate cancer	9.21e-06	0.000139	CcSEcCtD
Exemestane—Feeling abnormal—Epirubicin—prostate cancer	9.2e-06	0.000139	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	9.2e-06	0.000353	CbGpPWpGaD
Exemestane—Gastrointestinal pain—Epirubicin—prostate cancer	9.13e-06	0.000138	CcSEcCtD
Exemestane—Dyspepsia—Doxorubicin—prostate cancer	9.09e-06	0.000137	CcSEcCtD
Exemestane—CYP19A1—Metabolism—GSTA4—prostate cancer	9.09e-06	0.000349	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—TBXAS1—prostate cancer	9.09e-06	0.000349	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—TP53—prostate cancer	9.09e-06	0.000349	CbGpPWpGaD
Exemestane—Vomiting—Prednisone—prostate cancer	9.08e-06	0.000137	CcSEcCtD
Exemestane—Rash—Prednisone—prostate cancer	9e-06	0.000136	CcSEcCtD
Exemestane—Dermatitis—Prednisone—prostate cancer	8.99e-06	0.000136	CcSEcCtD
Exemestane—Decreased appetite—Doxorubicin—prostate cancer	8.98e-06	0.000135	CcSEcCtD
Exemestane—Headache—Prednisone—prostate cancer	8.94e-06	0.000135	CcSEcCtD
Exemestane—Gastrointestinal disorder—Doxorubicin—prostate cancer	8.92e-06	0.000134	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	8.91e-06	0.000342	CbGpPWpGaD
Exemestane—Fatigue—Doxorubicin—prostate cancer	8.91e-06	0.000134	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	8.89e-06	0.000341	CbGpPWpGaD
Exemestane—Urticaria—Epirubicin—prostate cancer	8.87e-06	0.000134	CcSEcCtD
Exemestane—CYP19A1—Metabolism—GSTA2—prostate cancer	8.86e-06	0.00034	CbGpPWpGaD
Exemestane—Pain—Doxorubicin—prostate cancer	8.83e-06	0.000133	CcSEcCtD
Exemestane—Constipation—Doxorubicin—prostate cancer	8.83e-06	0.000133	CcSEcCtD
Exemestane—Body temperature increased—Epirubicin—prostate cancer	8.83e-06	0.000133	CcSEcCtD
Exemestane—Abdominal pain—Epirubicin—prostate cancer	8.83e-06	0.000133	CcSEcCtD
Exemestane—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	8.79e-06	0.000337	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SULT1A1—prostate cancer	8.75e-06	0.000336	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ABCG5—prostate cancer	8.75e-06	0.000336	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GGT1—prostate cancer	8.63e-06	0.000331	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTA1—prostate cancer	8.55e-06	0.000328	CbGpPWpGaD
Exemestane—Feeling abnormal—Doxorubicin—prostate cancer	8.51e-06	0.000128	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—NCOA1—prostate cancer	8.5e-06	0.000326	CbGpPWpGaD
Exemestane—Nausea—Prednisone—prostate cancer	8.48e-06	0.000128	CcSEcCtD
Exemestane—CYP19A1—Metabolism—HSD3B2—prostate cancer	8.45e-06	0.000324	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTO1—prostate cancer	8.45e-06	0.000324	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NAT2—prostate cancer	8.45e-06	0.000324	CbGpPWpGaD
Exemestane—Gastrointestinal pain—Doxorubicin—prostate cancer	8.45e-06	0.000127	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	8.38e-06	0.000322	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	8.26e-06	0.000317	CbGpPWpGaD
Exemestane—Hypersensitivity—Epirubicin—prostate cancer	8.23e-06	0.000124	CcSEcCtD
Exemestane—Urticaria—Doxorubicin—prostate cancer	8.21e-06	0.000124	CcSEcCtD
Exemestane—Body temperature increased—Doxorubicin—prostate cancer	8.17e-06	0.000123	CcSEcCtD
Exemestane—Abdominal pain—Doxorubicin—prostate cancer	8.17e-06	0.000123	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	8.13e-06	0.000312	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PLCB2—prostate cancer	8.1e-06	0.000311	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—LRP2—prostate cancer	8.1e-06	0.000311	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP2C18—prostate cancer	8.1e-06	0.000311	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—RXRA—prostate cancer	8.08e-06	0.00031	CbGpPWpGaD
Exemestane—Asthenia—Epirubicin—prostate cancer	8.01e-06	0.000121	CcSEcCtD
Exemestane—CYP19A1—Metabolism—P4HB—prostate cancer	7.95e-06	0.000305	CbGpPWpGaD
Exemestane—Pruritus—Epirubicin—prostate cancer	7.9e-06	0.000119	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—COMT—prostate cancer	7.79e-06	0.000299	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTP1—prostate cancer	7.75e-06	0.000298	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SLC22A1—prostate cancer	7.73e-06	0.000297	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	7.68e-06	0.000295	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—AKT1—prostate cancer	7.68e-06	0.000295	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	7.64e-06	0.000293	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	7.64e-06	0.000293	CbGpPWpGaD
Exemestane—Diarrhoea—Epirubicin—prostate cancer	7.64e-06	0.000115	CcSEcCtD
Exemestane—Hypersensitivity—Doxorubicin—prostate cancer	7.61e-06	0.000115	CcSEcCtD
Exemestane—CYP19A1—Metabolism—SULT2A1—prostate cancer	7.53e-06	0.000289	CbGpPWpGaD
Exemestane—Asthenia—Doxorubicin—prostate cancer	7.41e-06	0.000112	CcSEcCtD
Exemestane—CYP19A1—Metabolism—MED12—prostate cancer	7.41e-06	0.000284	CbGpPWpGaD
Exemestane—Dizziness—Epirubicin—prostate cancer	7.38e-06	0.000111	CcSEcCtD
Exemestane—CYP19A1—Metabolism—GNG5—prostate cancer	7.35e-06	0.000282	CbGpPWpGaD
Exemestane—Pruritus—Doxorubicin—prostate cancer	7.31e-06	0.00011	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—GSTM1—prostate cancer	7.12e-06	0.000273	CbGpPWpGaD
Exemestane—Vomiting—Epirubicin—prostate cancer	7.1e-06	0.000107	CcSEcCtD
Exemestane—CYP19A1—Metabolism—NCOA3—prostate cancer	7.08e-06	0.000272	CbGpPWpGaD
Exemestane—Diarrhoea—Doxorubicin—prostate cancer	7.07e-06	0.000107	CcSEcCtD
Exemestane—Rash—Epirubicin—prostate cancer	7.04e-06	0.000106	CcSEcCtD
Exemestane—Dermatitis—Epirubicin—prostate cancer	7.03e-06	0.000106	CcSEcCtD
Exemestane—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	7.02e-06	0.00027	CbGpPWpGaD
Exemestane—Headache—Epirubicin—prostate cancer	6.99e-06	0.000105	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	6.96e-06	0.000267	CbGpPWpGaD
Exemestane—Dizziness—Doxorubicin—prostate cancer	6.83e-06	0.000103	CcSEcCtD
Exemestane—CYP19A1—Metabolism—HPGDS—prostate cancer	6.76e-06	0.000259	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	6.75e-06	0.000259	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP2C19—prostate cancer	6.71e-06	0.000258	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HAO1—prostate cancer	6.66e-06	0.000256	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	6.66e-06	0.000256	CbGpPWpGaD
Exemestane—Nausea—Epirubicin—prostate cancer	6.63e-06	0.0001	CcSEcCtD
Exemestane—Vomiting—Doxorubicin—prostate cancer	6.57e-06	9.9e-05	CcSEcCtD
Exemestane—CYP19A1—Metabolism—GSTT1—prostate cancer	6.55e-06	0.000252	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ACHE—prostate cancer	6.55e-06	0.000252	CbGpPWpGaD
Exemestane—Rash—Doxorubicin—prostate cancer	6.51e-06	9.82e-05	CcSEcCtD
Exemestane—Dermatitis—Doxorubicin—prostate cancer	6.51e-06	9.81e-05	CcSEcCtD
Exemestane—CYP19A1—Metabolism—CYP2A6—prostate cancer	6.48e-06	0.000249	CbGpPWpGaD
Exemestane—Headache—Doxorubicin—prostate cancer	6.47e-06	9.76e-05	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	6.45e-06	0.000248	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—AKR1C3—prostate cancer	6.3e-06	0.000242	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PRKACB—prostate cancer	6.27e-06	0.000241	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP17A1—prostate cancer	6.2e-06	0.000238	CbGpPWpGaD
Exemestane—Nausea—Doxorubicin—prostate cancer	6.14e-06	9.25e-05	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	6.12e-06	0.000235	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NCOA2—prostate cancer	5.91e-06	0.000227	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SLC5A5—prostate cancer	5.64e-06	0.000216	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP2E1—prostate cancer	5.51e-06	0.000211	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NQO1—prostate cancer	5.45e-06	0.000209	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CSAD—prostate cancer	5.43e-06	0.000209	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ADI1—prostate cancer	5.43e-06	0.000209	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—TST—prostate cancer	5.43e-06	0.000209	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CBR1—prostate cancer	5.43e-06	0.000209	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GRHL1—prostate cancer	5.43e-06	0.000209	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PSAT1—prostate cancer	5.43e-06	0.000209	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—TH—prostate cancer	5.37e-06	0.000206	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.33e-06	0.000205	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP3A4—prostate cancer	5.31e-06	0.000204	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.28e-06	0.000203	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP1B1—prostate cancer	5.22e-06	0.0002	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GGT1—prostate cancer	5.06e-06	0.000194	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GRHPR—prostate cancer	5.05e-06	0.000194	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CKMT2—prostate cancer	5.05e-06	0.000194	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—UGT2B17—prostate cancer	5.05e-06	0.000194	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—UGT2B15—prostate cancer	5.05e-06	0.000194	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NCOA1—prostate cancer	4.98e-06	0.000191	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—RFK—prostate cancer	4.75e-06	0.000182	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NAGLU—prostate cancer	4.75e-06	0.000182	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AOX1—prostate cancer	4.75e-06	0.000182	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PGAM2—prostate cancer	4.75e-06	0.000182	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—MBTPS1—prostate cancer	4.75e-06	0.000182	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SULT2B1—prostate cancer	4.75e-06	0.000182	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTM3—prostate cancer	4.75e-06	0.000182	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—RXRA—prostate cancer	4.74e-06	0.000182	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.61e-06	0.000177	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—COMT—prostate cancer	4.56e-06	0.000175	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTP1—prostate cancer	4.54e-06	0.000174	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AMACR—prostate cancer	4.5e-06	0.000173	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP3A43—prostate cancer	4.5e-06	0.000173	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SRD5A2—prostate cancer	4.5e-06	0.000173	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—DEGS1—prostate cancer	4.5e-06	0.000173	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NAT1—prostate cancer	4.5e-06	0.000173	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ITPR1—prostate cancer	4.47e-06	0.000172	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.39e-06	0.000169	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HSD17B1—prostate cancer	4.29e-06	0.000165	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—TYMS—prostate cancer	4.22e-06	0.000162	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTM1—prostate cancer	4.17e-06	0.00016	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—LPL—prostate cancer	4.1e-06	0.000157	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP1A1—prostate cancer	3.96e-06	0.000152	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ERCC2—prostate cancer	3.92e-06	0.000151	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—B4GALT4—prostate cancer	3.83e-06	0.000147	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HPGD—prostate cancer	3.83e-06	0.000147	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—MTHFR—prostate cancer	3.69e-06	0.000142	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PPARA—prostate cancer	3.62e-06	0.000139	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—TNFRSF21—prostate cancer	3.6e-06	0.000138	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP7B1—prostate cancer	3.5e-06	0.000134	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—MTAP—prostate cancer	3.5e-06	0.000134	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SULT1E1—prostate cancer	3.41e-06	0.000131	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SRD5A1—prostate cancer	3.41e-06	0.000131	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CAV1—prostate cancer	3.4e-06	0.000131	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ACSL4—prostate cancer	3.25e-06	0.000125	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HSD17B3—prostate cancer	3.25e-06	0.000125	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.25e-06	0.000125	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PHGDH—prostate cancer	3.12e-06	0.00012	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—UMPS—prostate cancer	3.12e-06	0.00012	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ARG2—prostate cancer	3.12e-06	0.00012	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CG—prostate cancer	3.1e-06	0.000119	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—LDHB—prostate cancer	3.06e-06	0.000117	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP3A5—prostate cancer	3e-06	0.000115	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—INS—prostate cancer	2.93e-06	0.000113	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTA3—prostate cancer	2.9e-06	0.000111	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—TCN2—prostate cancer	2.9e-06	0.000111	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—UCP3—prostate cancer	2.9e-06	0.000111	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PDHA1—prostate cancer	2.9e-06	0.000111	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CREBBP—prostate cancer	2.87e-06	0.00011	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.77e-06	0.000106	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.77e-06	0.000106	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CD—prostate cancer	2.72e-06	0.000105	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTA4—prostate cancer	2.65e-06	0.000102	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.65e-06	0.000102	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTA2—prostate cancer	2.59e-06	9.92e-05	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NOS3—prostate cancer	2.57e-06	9.88e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ABCG5—prostate cancer	2.55e-06	9.8e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.55e-06	9.8e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTA1—prostate cancer	2.49e-06	9.58e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.47e-06	9.47e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NAT2—prostate cancer	2.47e-06	9.47e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTO1—prostate cancer	2.47e-06	9.47e-05	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CB—prostate cancer	2.37e-06	9.12e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PLCB2—prostate cancer	2.36e-06	9.08e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—LRP2—prostate cancer	2.36e-06	9.08e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.36e-06	9.08e-05	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PTGS2—prostate cancer	2.35e-06	9.03e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—P4HB—prostate cancer	2.32e-06	8.9e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.26e-06	8.66e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.2e-06	8.44e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—MED12—prostate cancer	2.16e-06	8.3e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GNG5—prostate cancer	2.15e-06	8.24e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NCOA3—prostate cancer	2.07e-06	7.93e-05	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PTEN—prostate cancer	2.05e-06	7.88e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HPGDS—prostate cancer	1.97e-06	7.57e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.96e-06	7.52e-05	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—EP300—prostate cancer	1.96e-06	7.51e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTT1—prostate cancer	1.91e-06	7.34e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ACHE—prostate cancer	1.91e-06	7.34e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.89e-06	7.26e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.84e-06	7.06e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PRKACB—prostate cancer	1.83e-06	7.02e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.81e-06	6.95e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NCOA2—prostate cancer	1.72e-06	6.62e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.65e-06	6.32e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.61e-06	6.17e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NQO1—prostate cancer	1.59e-06	6.1e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—TH—prostate cancer	1.57e-06	6.01e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.52e-06	5.85e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GGT1—prostate cancer	1.48e-06	5.67e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NCOA1—prostate cancer	1.45e-06	5.58e-05	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CA—prostate cancer	1.45e-06	5.56e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.43e-06	5.5e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—RXRA—prostate cancer	1.38e-06	5.31e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—COMT—prostate cancer	1.33e-06	5.11e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTP1—prostate cancer	1.33e-06	5.09e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ITPR1—prostate cancer	1.3e-06	5.01e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—TYMS—prostate cancer	1.23e-06	4.73e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTM1—prostate cancer	1.22e-06	4.68e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—LPL—prostate cancer	1.2e-06	4.59e-05	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—AKT1—prostate cancer	1.18e-06	4.54e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.15e-06	4.43e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ERCC2—prostate cancer	1.15e-06	4.4e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—MTHFR—prostate cancer	1.08e-06	4.13e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PPARA—prostate cancer	1.06e-06	4.05e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CAV1—prostate cancer	9.93e-07	3.81e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CG—prostate cancer	9.04e-07	3.47e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—INS—prostate cancer	8.56e-07	3.29e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CREBBP—prostate cancer	8.39e-07	3.22e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CD—prostate cancer	7.95e-07	3.05e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NOS3—prostate cancer	7.51e-07	2.88e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CB—prostate cancer	6.93e-07	2.66e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PTGS2—prostate cancer	6.87e-07	2.64e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PTEN—prostate cancer	5.99e-07	2.3e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—EP300—prostate cancer	5.71e-07	2.19e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.22e-07	1.62e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AKT1—prostate cancer	3.45e-07	1.32e-05	CbGpPWpGaD
